Changes in therapy over 10 years effective in early breast cancer Clinical study 02 February 2013 Pages: 2 - 2
Denosumab HALTs bone loss during AI therapy for breast cancer Meeting report 02 February 2013 Pages: 3 - 4
Concomitant or sequential capecitabine for breast cancer not convincing Clinical study 02 February 2013 Pages: 4 - 4
High-dose vs approved-dose fulvestrant for ER+ breast cancer Clinical study 02 February 2013 Pages: 4 - 4
Effects of anastrozole outlast treatment in HR+ breast cancer Meeting report 02 February 2013 Pages: 5 - 6
Docetaxel and trastuzumab-based therapies all good news for QOL Clinical study 02 February 2013 Pages: 6 - 6
Anthracycline benefits vastly restricted in breast cancer Clinical study 02 February 2013 Pages: 11 - 11
Risedronic acid abrogates anastrozole-induced bone loss Meeting report 02 February 2013 Pages: 12 - 12
Pertuzumab: encouraging early results in stage IV breast cancer Clinical study 02 February 2013 Pages: 14 - 14
Vandetanib activity in advanced breast cancer discouraging Clinical study 02 February 2013 Pages: 14 - 14
Docetaxel delivers over doxorubicin for early breast cancer Meeting report 02 February 2013 Pages: 15 - 16
Tipifarnib shows potential for locally advanced breast cancer Clinical study 02 February 2013 Pages: 16 - 16
Sunitinib + paclitaxel promising for advanced breast cancer Clinical study 02 February 2013 Pages: 18 - 18
Ospemifene shows promise in postmenopausal vaginal atrophy Media release 02 February 2013 Pages: 19 - 19
Personalised molecular medicine possible in muscular dystrophy? News item 02 February 2013 Pages: 20 - 20
PRX 03140 promising for cognitive functioning in Alzheimer's Media release 02 February 2013 Pages: 20 - 20
Quinolones affect noninfection-related mortality in cancer patients? Clinical study 02 February 2013 Pages: 21 - 21
Tetravalent meningococcal vax in infants: high immunogenicity News item 02 February 2013 Pages: 21 - 21
Antipsychotics for aggression unhelpful for intellectually disabled News item 02 February 2013 Pages: 22 - 22
Improving the poor understanding of ER-poor breast cancer treatment News item 02 February 2013 Pages: 23 - 23
Single- vs multiple-dose methotrexate for ectopic pregnancy Clinical study 02 February 2013 Pages: 23 - 23
Extended anastrozole beneficial in postmenopausal breast cancer Media release 02 February 2013 Pages: 24 - 24
Gabapentin beneficial in high altitude-related symptoms Clinical study 02 February 2013 Pages: 24 - 24
Hormonal contraceptives lower bacterial vaginosis risk Clinical study 02 February 2013 Pages: 24 - 24
Oral bisphosphonates reduce the risk of jaw degradation Media release 02 February 2013 Pages: 24 - 24
Rosuvastatin concentrations increased with lopinavir/ritonavir News item 02 February 2013 Pages: 24 - 24
Bisphosphonate-related severe pain should not be overlooked News item 02 February 2013 Pages: 25 - 25
Adalimumab receives marketing authorisation in the EU for psoriasis Media release 02 February 2013 Pages: 26 - 26